|

The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study

RECRUITINGSponsored by The Institute of Molecular and Translational Medicine, Czech Republic
Actively Recruiting
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic
Started2023-05-02
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07112937

Summary

The prospective study will focus on patients undergoing multimodal treatment for rectal cancer. The main objective of the study will be to monitor changes in circulating tumor cells (CTCs) in the peripheral blood of patients during multimodal treatment. For each patient enrolled in the study, peripheral blood samples will be collected at specified time intervals to determine the presence and quantity of CTCs. The CTCs levels will be compared among rectal cancer patients with neoadjuvant chemoradiotherapy and without neoadjuvant chemotherapy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: rectal cancer -

Exclusion Criteria: no other cancer

\-

Conditions2

CancerRectal Cancer Patients

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.